The International Stem Cell Institute (ISCI) is a pioneering force in regenerative medicine, dedicated to advancing healthcare and enhancing quality of life. Established in 2011, ISCI has positioned itself at the forefront of the biotechnology industry, specializing in cutting-edge stem cell therapies. With its base in Bogota, Colombia, ISCI boasts a global reach and is committed to leveraging stem cell technologies to address a range of chronic conditions, prioritizing personalized patient care and innovative treatments.
At ISCI, a team of renowned experts is leading the charge in pushing the boundaries of medical science, driving forward with state-of-the-art therapies and groundbreaking research. The institute's mission is centered on ushering in a future where regenerative medicine plays a pivotal role in transforming healing and wellness for patients worldwide.
The most recent milestone for ISCI was marked by the Seed Round investment secured on December 12, 2023. This strategic injection of funding underscores the confidence of investors in the institute’s vision and capabilities. As ISCI continues to gain support and investment, it is poised to further cement its position as a leading authority in regenerative medicine, poised to bring about transformative advancements in patient care and health outcomes.
